Main Menu

Our therapeutic pipeline

The Institute of Cancer Research is the world’s leading academic centre for cancer drug discovery. Our scientists have discovered 21 new drug candidates since 2005, of which 13 have entered clinical trials, thanks to collaborations with our industry partners.

We also run one of the most successful academic drug development programmes in the world, in partnership with The Royal Marsden NHS Foundation Trust.

Graphic depicting the ICR's therapeutic pipeline

More about our programmes

Each of the compounds to reach clinical trials has emerged from collaborative programmes involving multiple partners. The ICR is one of the world’s leading academic centres for industry collaboration and establishes long-term, fruitful and effective partnerships with industry. Find out more about each programme via the links below.